- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Transplant Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Transplant Diagnostics market size is estimated to be worth US$ 3960 million in 2021 and is forecast to a readjusted size of USD 5645.6 million by 2028 with a CAGR of 5.2% during review period. Independent Reference Laboratories accounting for % of the Transplant Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solid Organ Transplantation segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Transplant Diagnostics include BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, and Caredx, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transplant Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solid Organ Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation
Market segment by Application, can be divided into
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Market segment by players, this report covers
BD
Biofortuna
Biomérieux SA
Bio-Rad Laboratories
Caredx
F. Hoffman-La Roche
Gendx
Hologic
Illumina
Immucor
Luminex
Merck KGaA
Omixon
Qiagen
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Transplant Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Transplant Diagnostics, with revenue, gross margin and global market share of Transplant Diagnostics from 2019 to 2022.
Chapter 3, the Transplant Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transplant Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Transplant Diagnostics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Transplant Diagnostics
1.2 Classification of Transplant Diagnostics by Type
1.2.1 Overview: Global Transplant Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Transplant Diagnostics Revenue Market Share by Type in 2021
1.2.3 Solid Organ Transplantation
1.2.4 Stem Cell Transplantation
1.2.5 Soft Tissue Transplantation
1.2.6 Bone Marrow Transplantation
1.3 Global Transplant Diagnostics Market by Application
1.3.1 Overview: Global Transplant Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals & Transplant Centers
1.3.4 Research Laboratories & Academic Institutes
1.4 Global Transplant Diagnostics Market Size & Forecast
1.5 Global Transplant Diagnostics Market Size and Forecast by Region
1.5.1 Global Transplant Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Transplant Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Transplant Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Transplant Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Transplant Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Transplant Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Transplant Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transplant Diagnostics Market Drivers
1.6.2 Transplant Diagnostics Market Restraints
1.6.3 Transplant Diagnostics Trends Analysis
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Transplant Diagnostics Product and Solutions
2.1.4 BD Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 BD Recent Developments and Future Plans
2.2 Biofortuna
2.2.1 Biofortuna Details
2.2.2 Biofortuna Major Business
2.2.3 Biofortuna Transplant Diagnostics Product and Solutions
2.2.4 Biofortuna Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Biofortuna Recent Developments and Future Plans
2.3 Biomérieux SA
2.3.1 Biomérieux SA Details
2.3.2 Biomérieux SA Major Business
2.3.3 Biomérieux SA Transplant Diagnostics Product and Solutions
2.3.4 Biomérieux SA Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Biomérieux SA Recent Developments and Future Plans
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business
2.4.3 Bio-Rad Laboratories Transplant Diagnostics Product and Solutions
2.4.4 Bio-Rad Laboratories Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.5 Caredx
2.5.1 Caredx Details
2.5.2 Caredx Major Business
2.5.3 Caredx Transplant Diagnostics Product and Solutions
2.5.4 Caredx Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Caredx Recent Developments and Future Plans
2.6 F. Hoffman-La Roche
2.6.1 F. Hoffman-La Roche Details
2.6.2 F. Hoffman-La Roche Major Business
2.6.3 F. Hoffman-La Roche Transplant Diagnostics Product and Solutions
2.6.4 F. Hoffman-La Roche Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.7 Gendx
2.7.1 Gendx Details
2.7.2 Gendx Major Business
2.7.3 Gendx Transplant Diagnostics Product and Solutions
2.7.4 Gendx Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Gendx Recent Developments and Future Plans
2.8 Hologic
2.8.1 Hologic Details
2.8.2 Hologic Major Business
2.8.3 Hologic Transplant Diagnostics Product and Solutions
2.8.4 Hologic Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Hologic Recent Developments and Future Plans
2.9 Illumina
2.9.1 Illumina Details
2.9.2 Illumina Major Business
2.9.3 Illumina Transplant Diagnostics Product and Solutions
2.9.4 Illumina Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Illumina Recent Developments and Future Plans
2.10 Immucor
2.10.1 Immucor Details
2.10.2 Immucor Major Business
2.10.3 Immucor Transplant Diagnostics Product and Solutions
2.10.4 Immucor Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Immucor Recent Developments and Future Plans
2.11 Luminex
2.11.1 Luminex Details
2.11.2 Luminex Major Business
2.11.3 Luminex Transplant Diagnostics Product and Solutions
2.11.4 Luminex Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Luminex Recent Developments and Future Plans
2.12 Merck KGaA
2.12.1 Merck KGaA Details
2.12.2 Merck KGaA Major Business
2.12.3 Merck KGaA Transplant Diagnostics Product and Solutions
2.12.4 Merck KGaA Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Merck KGaA Recent Developments and Future Plans
2.13 Omixon
2.13.1 Omixon Details
2.13.2 Omixon Major Business
2.13.3 Omixon Transplant Diagnostics Product and Solutions
2.13.4 Omixon Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Omixon Recent Developments and Future Plans
2.14 Qiagen
2.14.1 Qiagen Details
2.14.2 Qiagen Major Business
2.14.3 Qiagen Transplant Diagnostics Product and Solutions
2.14.4 Qiagen Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Qiagen Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Transplant Diagnostics Product and Solutions
2.15.4 Thermo Fisher Scientific Transplant Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transplant Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Transplant Diagnostics Players Market Share in 2021
3.2.2 Top 10 Transplant Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Transplant Diagnostics Players Head Office, Products and Services Provided
3.4 Transplant Diagnostics Mergers & Acquisitions
3.5 Transplant Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transplant Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Transplant Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Transplant Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Transplant Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Transplant Diagnostics Revenue by Type (2017-2028)
6.2 North America Transplant Diagnostics Revenue by Application (2017-2028)
6.3 North America Transplant Diagnostics Market Size by Country
6.3.1 North America Transplant Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Transplant Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Transplant Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Transplant Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Transplant Diagnostics Revenue by Type (2017-2028)
7.2 Europe Transplant Diagnostics Revenue by Application (2017-2028)
7.3 Europe Transplant Diagnostics Market Size by Country
7.3.1 Europe Transplant Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Transplant Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Transplant Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Transplant Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Transplant Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Transplant Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transplant Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Transplant Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Transplant Diagnostics Market Size by Region
8.3.1 Asia-Pacific Transplant Diagnostics Revenue by Region (2017-2028)
8.3.2 China Transplant Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Transplant Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Transplant Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Transplant Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Transplant Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Transplant Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Transplant Diagnostics Revenue by Type (2017-2028)
9.2 South America Transplant Diagnostics Revenue by Application (2017-2028)
9.3 South America Transplant Diagnostics Market Size by Country
9.3.1 South America Transplant Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Transplant Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Transplant Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transplant Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Transplant Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Transplant Diagnostics Market Size by Country
10.3.1 Middle East & Africa Transplant Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Transplant Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Transplant Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Transplant Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Transplant Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Transplant Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Transplant Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Transplant Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Transplant Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. BD Corporate Information, Head Office, and Major Competitors
Table 7. BD Major Business
Table 8. BD Transplant Diagnostics Product and Solutions
Table 9. BD Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Biofortuna Corporate Information, Head Office, and Major Competitors
Table 11. Biofortuna Major Business
Table 12. Biofortuna Transplant Diagnostics Product and Solutions
Table 13. Biofortuna Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Biomérieux SA Corporate Information, Head Office, and Major Competitors
Table 15. Biomérieux SA Major Business
Table 16. Biomérieux SA Transplant Diagnostics Product and Solutions
Table 17. Biomérieux SA Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Bio-Rad Laboratories Major Business
Table 20. Bio-Rad Laboratories Transplant Diagnostics Product and Solutions
Table 21. Bio-Rad Laboratories Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Caredx Corporate Information, Head Office, and Major Competitors
Table 23. Caredx Major Business
Table 24. Caredx Transplant Diagnostics Product and Solutions
Table 25. Caredx Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. F. Hoffman-La Roche Corporate Information, Head Office, and Major Competitors
Table 27. F. Hoffman-La Roche Major Business
Table 28. F. Hoffman-La Roche Transplant Diagnostics Product and Solutions
Table 29. F. Hoffman-La Roche Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Gendx Corporate Information, Head Office, and Major Competitors
Table 31. Gendx Major Business
Table 32. Gendx Transplant Diagnostics Product and Solutions
Table 33. Gendx Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Hologic Corporate Information, Head Office, and Major Competitors
Table 35. Hologic Major Business
Table 36. Hologic Transplant Diagnostics Product and Solutions
Table 37. Hologic Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Illumina Corporate Information, Head Office, and Major Competitors
Table 39. Illumina Major Business
Table 40. Illumina Transplant Diagnostics Product and Solutions
Table 41. Illumina Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Immucor Corporate Information, Head Office, and Major Competitors
Table 43. Immucor Major Business
Table 44. Immucor Transplant Diagnostics Product and Solutions
Table 45. Immucor Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Luminex Corporate Information, Head Office, and Major Competitors
Table 47. Luminex Major Business
Table 48. Luminex Transplant Diagnostics Product and Solutions
Table 49. Luminex Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 51. Merck KGaA Major Business
Table 52. Merck KGaA Transplant Diagnostics Product and Solutions
Table 53. Merck KGaA Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Omixon Corporate Information, Head Office, and Major Competitors
Table 55. Omixon Major Business
Table 56. Omixon Transplant Diagnostics Product and Solutions
Table 57. Omixon Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Qiagen Corporate Information, Head Office, and Major Competitors
Table 59. Qiagen Major Business
Table 60. Qiagen Transplant Diagnostics Product and Solutions
Table 61. Qiagen Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 63. Thermo Fisher Scientific Major Business
Table 64. Thermo Fisher Scientific Transplant Diagnostics Product and Solutions
Table 65. Thermo Fisher Scientific Transplant Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Transplant Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Transplant Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Transplant Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Transplant Diagnostics Players Head Office, Products and Services Provided
Table 70. Transplant Diagnostics Mergers & Acquisitions in the Past Five Years
Table 71. Transplant Diagnostics New Entrants and Expansion Plans
Table 72. Global Transplant Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 73. Global Transplant Diagnostics Revenue Share by Type (2017-2022)
Table 74. Global Transplant Diagnostics Revenue Forecast by Type (2023-2028)
Table 75. Global Transplant Diagnostics Revenue by Application (2017-2022)
Table 76. Global Transplant Diagnostics Revenue Forecast by Application (2023-2028)
Table 77. North America Transplant Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Transplant Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Transplant Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Transplant Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Transplant Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Transplant Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Transplant Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Transplant Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Transplant Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Transplant Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Transplant Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Transplant Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Transplant Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Transplant Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Transplant Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Transplant Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Transplant Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Transplant Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Transplant Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Transplant Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Transplant Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Transplant Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Transplant Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Transplant Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Transplant Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Transplant Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Transplant Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Transplant Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Transplant Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Transplant Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Transplant Diagnostics Picture
Figure 2. Global Transplant Diagnostics Revenue Market Share by Type in 2021
Figure 3. Solid Organ Transplantation
Figure 4. Stem Cell Transplantation
Figure 5. Soft Tissue Transplantation
Figure 6. Bone Marrow Transplantation
Figure 7. Transplant Diagnostics Revenue Market Share by Application in 2021
Figure 8. Independent Reference Laboratories Picture
Figure 9. Hospitals & Transplant Centers Picture
Figure 10. Research Laboratories & Academic Institutes Picture
Figure 11. Global Transplant Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Transplant Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Transplant Diagnostics Revenue Market Share by Region (2017-2028)
Figure 14. Global Transplant Diagnostics Revenue Market Share by Region in 2021
Figure 15. North America Transplant Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Transplant Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Transplant Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Transplant Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Transplant Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Transplant Diagnostics Market Drivers
Figure 21. Transplant Diagnostics Market Restraints
Figure 22. Transplant Diagnostics Market Trends
Figure 23. BD Recent Developments and Future Plans
Figure 24. Biofortuna Recent Developments and Future Plans
Figure 25. Biomérieux SA Recent Developments and Future Plans
Figure 26. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 27. Caredx Recent Developments and Future Plans
Figure 28. F. Hoffman-La Roche Recent Developments and Future Plans
Figure 29. Gendx Recent Developments and Future Plans
Figure 30. Hologic Recent Developments and Future Plans
Figure 31. Illumina Recent Developments and Future Plans
Figure 32. Immucor Recent Developments and Future Plans
Figure 33. Luminex Recent Developments and Future Plans
Figure 34. Merck KGaA Recent Developments and Future Plans
Figure 35. Omixon Recent Developments and Future Plans
Figure 36. Qiagen Recent Developments and Future Plans
Figure 37. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 38. Global Transplant Diagnostics Revenue Share by Players in 2021
Figure 39. Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Transplant Diagnostics Revenue Market Share in 2021
Figure 41. Global Top 10 Players Transplant Diagnostics Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Transplant Diagnostics Revenue Share by Type in 2021
Figure 44. Global Transplant Diagnostics Market Share Forecast by Type (2023-2028)
Figure 45. Global Transplant Diagnostics Revenue Share by Application in 2021
Figure 46. Global Transplant Diagnostics Market Share Forecast by Application (2023-2028)
Figure 47. North America Transplant Diagnostics Sales Market Share by Type (2017-2028)
Figure 48. North America Transplant Diagnostics Sales Market Share by Application (2017-2028)
Figure 49. North America Transplant Diagnostics Revenue Market Share by Country (2017-2028)
Figure 50. United States Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Transplant Diagnostics Sales Market Share by Type (2017-2028)
Figure 54. Europe Transplant Diagnostics Sales Market Share by Application (2017-2028)
Figure 55. Europe Transplant Diagnostics Revenue Market Share by Country (2017-2028)
Figure 56. Germany Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Transplant Diagnostics Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Transplant Diagnostics Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Transplant Diagnostics Revenue Market Share by Region (2017-2028)
Figure 64. China Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Transplant Diagnostics Sales Market Share by Type (2017-2028)
Figure 71. South America Transplant Diagnostics Sales Market Share by Application (2017-2028)
Figure 72. South America Transplant Diagnostics Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Transplant Diagnostics Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Transplant Diagnostics Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Transplant Diagnostics Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Transplant Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
